Giuseppe Curigliano

📄 Out now – the ERS & EULAR - European Alliance of Associations for Rheumatology clinical practice guideline on connective tissue diseases with ILD involvement has now been published in the European Respiratory Journal. Access the new guideline online: https://lnkd.in/epV8XHrX

202

1 commento

Last week marked a major milestone in our continued commitment to clinical and scientific excellence: the launch of three new clinics in Italy—IVI Rome, IVI Bologna, and IVI Cattolica. From next-generation embryology infrastructure to personalized treatment programs, these centers represent our latest step in translating science into better outcomes. In Rome and Bologna, our new clinics now stand as the most technologically advanced fertility centers in Italy, with features such as an unmatched monitoring system that safeguards gametes and embryos around-the-clock. These openings are a product of over a decade of dedication by our teams in Italy, whose work has established IVI as a leader in clinical rigor, academic leadership, and evidence-based, patient-centered care. This post marks the beginning of a Care by Design series, where we will share how our strategic investments are shaping the future of fertility care around the world. Stay tuned for more on regional "firsts" and innovations in lab technology, clinical practice, and the patient experience. #IVIItaly #ReproductiveMedicine #ClinicalExcellence #Embryology #PatientCenteredCare #InnovationInFertility #FertilityCare #FutureOfIVF #CarebyDesign #IVIRMAGlobal

138

1 commento

We are pleased to announce that the European Society of Cardiology (ESC), together with the European Atherosclerosis Society (EAS), has published the 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias: https://lnkd.in/eyfVrsJS Since the publication of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular (CV) risk, there have been several randomized controlled trials that might change patient management ahead of the next scheduled full dyslipidaemia Guidelines. This 2025 Focused Update addresses changes in recommendations for the treatment of dyslipidaemias based on new evidence published up until March 31, 2025.

480

7 commenti

WE in ACTION 2025 has officially started, a program dedicated to melanoma prevention. The day highlighted two key pillars in the fight against this disease: the critical importance of early diagnosis and the remarkable progress of research, which is continuously expanding therapeutic perspectives. Today, melanoma can be managed with increasingly effective interventions-provided it is identified promptly. The evidence is clear: while individual vigilance is essential, collective engagement -of families, healthcare professionals, and researchers- is what truly strengthens outcomes. Each stakeholder has a distinct and indispensable role in reducing the burden of melanoma. Research efforts are ongoing, and with the contribution of the entire community, we can move toward a future marked by earlier detection, more effective treatments, and improved patient survival. https://lnkd.in/dVV4DbrX #Teamwork #Melanoma #Prevention #Research

89

1 commento